BioMark Diagnostics Inc C.BUX

Alternate Symbol(s): BMKDF

BioMark Diagnostics Inc. is a liquid biopsy company. The Company is developing a molecular diagnostics technology platform, which leverages the power of metabolomics and machine learning algorithms to bring new cancer diagnostics to market and improve cancer prognosis by allowing physicians to detect carcinomas in the pre-symptomatic stages. The technology can also be used for measuring response to treatment and potentially for serial monitoring of cancer survivors. Its cancer diagnostics technology platform leverages Omics and machine learning with a focus on cancers that are hard to detect and treat. Its liquid biopsy assay detects Spermidine/spermine N-acetyltransferase 1 (SSAT1). SSAT1 is an enzyme with elevated levels in numerous cancers. It has also developed a new high powered liquid biopsy metabolic panel assay. The new metabolic assay is instrumental for early-stage diagnosis of lung cancer. The liquid biopsy metabolic panel has demonstrated clinical detections.

CSE:BUX - Post by User

BioMark Diagnostics Inc

<< Previous

Bullboard Posts

Next >>

Post by geodcanon Apr 11, 2024 8:21pm

50 Views

Post# 35984587

my bid must be chopped liver!

Shareprice is not free market imho. I have had a bid in for shares to add to my shares for well over 6 months and it is mid 4 figures, so not chicken feed.

My current bid is higher than my first entry point and nothing!

<< Previous

Bullboard Posts

Next >>

Fobi AI could address a market in the trillions: Why it's time to buy